Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

OCULOCUL
Showing 7 of 19 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in OCULAR THERAPEUTIX INC

BALYASNY ASSET MANAGEMENT L.P. holds 2.3M shares of OCUL (OCULAR THERAPEUTIX INC), worth $22.3M as of 2026-Q2. The position was decreased (-15.7% shares). OCUL represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$22.3M

Current Shares

2.3M

Total Value Change

+$21.5M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.3M
-15.7%
$22.3M0.0%$9.82
0
2026-Q1
Increased
2.7M
+252.6%
$22.8M0.0%$10.76
46
2025-Q4
Decreased
763,559
-65.1%
$9.3M0.0%$12.20
0
2025-Q3
Increased
2.2M
+902.9%
$25.6M0.0%$12.53
46
2025-Q2
Increased
218,293
+187.7%
$2M0.0%$9.22
42
2025-Q1
Decreased
75,869
-22.2%
$556,1200.0%$7.58
0
2024-Q4
New
97,553
-
$833,1030.0%$8.35
34

Other major holders of OCUL: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used